This makes semaglutide a highly attractive candidate for further weight loss research
Initially developed to help Type 2 diabetes patients manage blood sugar levels, these drugs have demonstrated extraordinary potential in weight loss, cardiovascular health , and other emerging therapeutic areas
Injection site reactions are the most commonly reported dermatological effects with subcutaneous semaglutide (Ozempic and Wegovy) and typically present as redness, itching, bruising, or mild swelling at the site of administration
If you need assistance, please contact our support team.
A part of Watch Medier Senior Medical Specialist, Therapeutic Areas - Global Clinical Development Laboratoriechef Pharma, Kosmetik & Helse, Biofac/1948 Regulatory Affairs Manager, Chr
Rotate your injection sites across your abdomen instead of using the same spot every time